Project Grant HT94252510330
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
The Regents of the University of California, San Francisco was awarded a $484,500 Project Grant from the Defense Health Agency to support research titled "Synergistic Combination Treatment of Prostate Cancer Using CD46- Targeted Antibody-Drug Conjugate and Radioimmunotherapy." The two-year award beginning March 1, 2023 will fund the development of innovative medical solutions for prostate cancer through the Military Medical Research and Development program (CFDA 12.420). This program...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...
This $1,211,127 Project Grant awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports a research project by the University of California, San Francisco (UCSF) to investigate the importance of immune responses to prostate tumor antigens primed by a combination of radiation and immunotherapy. The 4-year project aims to advance understanding of how to leverage the body's immune system to improve treatments for prostate cancer. As...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This $854,219 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to translate a first-in-class PET radiotracer for assessing ferroaddiction as a therapeutic vulnerability in advanced prostate cancer. The 3-year project, running from July 2024 to June 2027, aims to develop this innovative molecular imaging approach to improve treatment selection...
This federal Project Grant award of $1,801,179.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating the "Contribution of Bone Mass and Fracture to Bone Metastasis in Prostate Cancer" at the University of California, Davis. The research aims to transform healthcare for military service members and the general public through innovative and...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,228,594.00 to the Regents of the University of California, San Francisco (UCSF) for research on bispecific antibody-drug conjugates against emerging targets in metastatic lethal prostate cancer. The award period is from April 15, 2024 to April 14, 2027. As a leading academic medical center and research institution, UCSF will leverage its...
The Defense Health Agency awarded a $468,000 Project Grant to the University of California, Los Angeles under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research developing new therapeutic strategies to target TROP2 in aggressive prostate cancer. The two-year award beginning March 15, 2023 will fund research efforts to investigate medical solutions for prostate cancer on the battlefield and transform health care for service members and the public...
This federal Project Grant award, valued at $1,312,000.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research efforts by the Regents of the University of California, San Francisco (UCSF) to upregulate and image Nectin4 in order to enhance Nectin4-targeted therapies for bladder cancer. The 4-year award, with a performance period from August 1, 2025 to July 31, 2029, will enable UCSF researchers to investigate...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,008,313 to The Regents of the University of California, San Francisco (UCSF) for a 3-year period from Sep 1, 2024 to Aug 31, 2027. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. UCSF, a prominent academic medical center and research institution,...